Jonathan S. Zager

Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma

Robert H.I. Andtbacka, Howard L. Kaufman, Frances A. Collichio et al. · Journal of Clinical Oncology · 2015 · 2.6K citations · Full text

Medicine, Immunology, Oncology +17

Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma

Mark B. Faries, John F. Thompson, Alistair J. Cochran et al. · New England Journal of Medicine · 2017 · 1.4K citations · Full text

Medicine, Oncology, Surgery +17

Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial

Robert H.I. Andtbacka, Merrick Ross, Igor Puzanov et al. · Annals of Surgical Oncology · 2016 · 302 citations · Full text

Medicine, Immunology, Oncology +17

Clinicopathologic Predictors of Sentinel Lymph Node Metastasis in Thin Melanoma

Dale Han, Jonathan S. Zager, Yu Shyr et al. · Journal of Clinical Oncology · 2013 · 223 citations

Medicine, Oncology, Surgery +17

Efficacy of Adoptive Cell Transfer of Tumor-infiltrating Lymphocytes After Lymphopenia Induction for Metastatic Melanoma

Shari Pilon‐Thomas, Lisa Kühn, Sabine Ellwanger et al. · Journal of Immunotherapy · 2012 · 193 citations

Life Sciences, Immunology, Oncology +14